Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2717896 Title: THERAPEUTIKA ZUR REGULIERUNG DES PHOSPHATGEHALTS IM SERUM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127289072
WO application number:
US2012041759
Type:
European patent granted for BE
Status:
Open
Publication number:
2717896
WO publication number:
WO2012170955
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
08/06/2012
Grant date:
24/08/2016
EP publication date:
16/04/2014
WO publication date:
13/12/2012
Claims translation received date:
Translation received date (EP publication B1):
24/11/2016
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
24/08/2016
EP B1 publication date:
24/08/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
08/06/2032

Applicant

Name:
Kai Pharmaceuticals, Inc.
Legal Form:
From:
24/08/2016
Address:
270 Littlefield Avenue, South San Francisco, CA 94080, United States (US)
To:

Agent

Name:
STOLMAR Matthias
Legal Form:
From:
24/11/2016
Address:
Blumenstraße 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
KARIM, Felix
Legal Form:
Address:
Walnut Creek, CA 94596, United States (US)

2

Name:
BELL, Gregory
Legal Form:
Address:
Tiburon, CA 94061, United States (US)

Priority

Priority patent number:
201161494874 P
Priority date:
08/06/2011
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 38/08; A61K 45/06; A61P 13/12; C07K 7/06;

Publication

Bulletin

Bulletin heading:
EP3
Journal edition number:
2016/11
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

European Patent Bulletin

Issue number:
201634
Publication date:
24/08/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/06/2026
Annual fee number:
15
Annual fee amount:
360 Euro
Expected payer:
Last annual fee payment date:
20/05/2025
Last annual fee paid number:
14
Last annual fee paid amount:
320 Euro
Payer:
ANAQUA SERVICES
Filing date Document type Publication Type Document Description Number of pages File Type
24/11/2016 Incoming Correspondence (Email) Cover letter 1 PDF /2/6/1/8/3/0721538162/docs/127289072_0_incomingcorrespondenceelectronic_20161125_082910012.pdf
24/11/2016 Translations 153 PDF /2/6/1/8/3/0721538162/docs/127289072_1_translations_20161125_082906438.pdf